Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/10/2017 01/11/2017 01/12/2017 01/13/2017 01/17/2017 Date
4.94(c) 4.89(c) 4.91(c) 4.91(c) 4.81 Last
52 519 99 690 88 795 49 549 41 822 Volume
+0.41% -1.01% +0.41% 0.00% -2.04% Change
More quotes
Financials ($)
More Financials
Company
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products.Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair.The company was founded by Peter A. Friedli and James S. Burns on... 
More about the company
Latest news on OSIRIS THERAPEUTICS, INC.
01/14 OSIRIS THERAPEUTICS : Announces Scientific Manuscript Reporting Antimicrobial Pr..
01/13 Osiris Therapeutics Announces Scientific Manuscript Reporting Antimicrobial P..
01/12 OSIRIS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continue..
2016 OSIRIS THERAPEUTICS : Provides Update Regarding NASDAQ Listing Matters
2016 OSIRIS THERAPEUTICS : Provides Update Regarding NASDAQ Listing Matters
2016 OSIRIS THERAPEUTICS,INC. (NASDAQ : OSIR) Files An 8-K Other Events
2016 OSIRIS THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (for..
2016 Osiris Provides Update Regarding NASDAQ Listing Matters
2016 Peer-reviewed Publication on the use of Grafix® in High-Risk Peripheral Arter..
2016 OSIRIS THERAPEUTICS : Provides Update Regarding NASDAQ Listing Matters
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Latest Tweets
01/06Want the latest upgrades & downgrades for $CPXGF $OSIR $UNM $EMCI $ZAVVV?.. 
2016$OSIR Osiris Therapeutics Grafix wound treatment product is now covered by Ae..
5
2016Want the latest upgrades & downgrades for $OSIR $ZAVVV $UNM $EMCI $CBD? C.. 
2016$OSIR: Osiris Therapeutics was granted additional time to file its delinquent.. 
More tweets
Qtime:36
News from SeekingAlpha
2016 Orthofix Poised To Plunge 50% On Undisclosed FDA Issue And Accounting Manipul..
2016 Adds and drops from the Nasdaq Biotech Index
2016 OSIRIS THERAPEUTICS : Regenerative Technologies And Restated Financials
2016 Midday Gainers / Losers
2016 Osiris Therapeutics releases revised revenue numbers; shares up 22%
Advertisement
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Technical analysis trends OSIRIS THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David A. Dresner President & Chief Executive Officer
Peter A. Friedli Chairman
Frank D. Czworka Chief Operating Officer
Gregory I. Law Chief Financial Officer, Secretary & Treasurer
Alla Danilkovitch Chief Scientific Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
OSIRIS THERAPEUTICS, I..0.00%169
AMGEN, INC.6.78%116 141
GILEAD SCIENCES, INC.2.04%96 267
CELGENE CORPORATION1.49%91 071
REGENERON PHARMACEUTIC..0.29%38 830
ACTELION LTD4.90%24 663
More Results